يعرض 1 - 10 نتائج من 19 نتيجة بحث عن '"Marieke J, Pierik"', وقت الاستعلام: 1.21s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    المساهمون: Interne Geneeskunde, RS: NUTRIM - R2 - Liver and digestive health, FHML Methodologie & Statistiek, RS: CAPHRI - R6 - Promoting Health & Personalised Care, MUMC+: MA Maag Darm Lever (9), Gastroenterology and hepatology, Amsterdam Gastroenterology Endocrinology Metabolism

    المصدر: van Moorsel, S A W, Deben, D S, Creemers, R H, Winkens, B, Bus, P, Pierik, M J, Simsek, M, de Boer, N K H, van Bodegraven, A A & Wong, D R 2022, ' Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients ', Therapeutic Drug Monitoring, vol. 44, no. 6, pp. 747-754 . https://doi.org/10.1097/FTD.0000000000001031
    Therapeutic Drug Monitoring, 44(6), 747-754. LIPPINCOTT WILLIAMS & WILKINS
    Therapeutic Drug Monitoring, 44(6), 747-754. Lippincott Williams and Wilkins

  8. 8
  9. 9
  10. 10

    المساهمون: Gastroenterology and hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology & Hepatology

    المصدر: Lancet Gastroenterology & Hepatology, 8, 4, pp. 343-355
    Lancet Gastroenterology & Hepatology, 8, 343-355
    The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd
    LADI study group and the Dutch Initiative on Crohn and Colitis 2023, ' Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI) : a pragmatic, open-label, non-inferiority, randomised controlled trial ', The Lancet Gastroenterology and Hepatology, vol. 8, no. 4, pp. 343-355 . https://doi.org/10.1016/S2468-1253(22)00434-4
    The Lancet Gastroenterology and Hepatology, 8(4), 343-355. Elsevier Ltd.